There is something different about the surroundings here—this is the first thought that crosses Patience Adhiambo’s, not her real name, mind as she stands just inside the gate of a place she never ...
The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...